|
2007 Conference Publication What is the optimal fat mass in peritoneal dialysis patients?Johnson, David W. (2007). What is the optimal fat mass in peritoneal dialysis patients?. 11th Congress of the International Society for Peritoneal Dialysis, Hong Kong, 25 - 29 August, 2006. Milton, Ontario: Multimed. |
|
2007 Conference Publication MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failureLiu, H., McTaggart, S., Li, J., Johnson, D. W. and Gobe, G. C. (2007). MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure. World Congress of Nephrology 2007, Rio de Janeiro, Brazil, 21-25 April 2007. International Society of Nephrology. |
|
2007 Conference Publication The impact of late referral to a nephrologist on access infections in peritoneal dialysis (PD) and haemodialysis (HD)Clark, C. J., Johnson, D., Hawley, C., May, K., Campbell, S., Isbel, N., Mudge, D. and Burke, J. (2007). The impact of late referral to a nephrologist on access infections in peritoneal dialysis (PD) and haemodialysis (HD). 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell. |
|
2007 Conference Publication Erythropoietin: Novel applications beyond anaemia treatmentVesey, D. A., Gobe, G. C. and Johnson, D. W. (2007). Erythropoietin: Novel applications beyond anaemia treatment. 2nd International Conference of Naresuan University, Phitsanulok, Thailand, 27-28 July, 2007. |
|
2007 Conference Publication The molecular and cellular changes associated with ageing and disease in the kidneyPercy, C., Brown, L., Johnson, D. W., Power, D. and Gobe, G. C. (2007). The molecular and cellular changes associated with ageing and disease in the kidney. Australian Society of Medical Research Annual Scientific Meeting, Blue Mountains NSW, November, 2007. |
|
2006 Journal Article Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell linesMorais, Christudas, Pat, Betty, Gobe, Glenda, Johnson, David W. and Healy, Helen (2006). Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines. Nephrology Dialysis Transplantation, 21 (12), 3377-3388. doi: 10.1093/ndt/gfl543 |
|
2006 Journal Article Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose-intolerant renal transplant recipientsArmstrong, Kirsten, Rakhit, Dhrubo, Jeffriess, Leanne, Johnson, David, Leano, Rodel, Prins, John, Garske, Luke, Marwick, Thomas and Isbel, Nicole (2006). Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose-intolerant renal transplant recipients. Clinical Journal of The American Society of Nephrology, 1 (6), 1275-1283. doi: 10.2215/CJN.00210106 |
|
2006 Journal Article A randomized controlled trial of coiled versus straight swan-neck tenckhoff catheters in peritoneal dialysis patientsJohnson, David W., Wong, Jennifer, Wiggins, Kathryn J., Kirwan, Robyn, Griffin, Anthony, Preston, John, Wall, Daryl, Campbell, Scott B., Isbel, Nicole M., Mudge, David W., Hawley, Carmel M. and Nicol, David L. (2006). A randomized controlled trial of coiled versus straight swan-neck tenckhoff catheters in peritoneal dialysis patients. American Journal of Kidney Diseases, 48 (5), 812-821. doi: 10.1053/j.ajkd.2006.08.010 |
|
2006 Journal Article Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysisTeigen, Mette Maja B., Duffull, Stephen, Dang, Lily and Johnson, David W. (2006). Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis. Journal of Clinical Pharmacology, 46 (11), 1259-1267. doi: 10.1177/0091270006292987 |
|
2006 Journal Article Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney diseaseRakhit, D. J., Marwick, T. H., Armstrong, K. A., Johnson, D. W., Leano, R. and Isbel, N. M. (2006). Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease. Heart, 92 (10), 1402-1408. doi: 10.1136/hrt.2005.074393 |
|
2006 Journal Article Novel renoprotective actions of erythropoietin: New uses for an old hormoneJohnson, David W., Forman, Colin and Vesey, David A. (2006). Novel renoprotective actions of erythropoietin: New uses for an old hormone. Nephrology, 11 (4), 306-312. doi: 10.1111/j.1440-1797.2006.00585.x |
|
2006 Journal Article Przewlekła choroba nerek: Uaktualnienie postępowaniaJohnson, David W. and Usherwood, Tim (2006). Przewlekła choroba nerek: Uaktualnienie postępowania. Lekarz Rodzinny (7-8 (107-108)), 802-810. |
|
2006 Journal Article A Randomized Controlled Trial of Fludrocortisone for the Treatment of Hyperkalemia in Hemodialysis PatientsKaisar, Mohammed O., Wiggins, Kathryn J., Sturtevant, Joanne M., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Mudge, David W., Bofinger, Andrew, Petrie, James J.B. and Johnson, David W. (2006). A Randomized Controlled Trial of Fludrocortisone for the Treatment of Hyperkalemia in Hemodialysis Patients. American Journal of Kidney Diseases, 47 (5), 809-814. doi: 10.1053/j.ajkd.2006.01.014 |
|
2006 Journal Article In replyMathew, Timothy H., Jones, Graham and Johnson, David (2006). In reply. Medical Journal of Australia, 184 (9), 476-477. doi: 10.5694/j.1326-5377.2006.tb00330.x |
|
2006 Journal Article Low protein diets for chronic kidney disease may be harmfulJohnson, D. W. (2006). Low protein diets for chronic kidney disease may be harmful. Renal & Urology News, xx-xx. |
|
2006 Journal Article Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failureJohnson, D. W., Pat, B., Vesey, D. A., Guan, Z., Endre, Z. and Gobe, G. C. (2006). Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney International, 69 (10), 1806-1813. doi: 10.1038/sj.ki.5000356 |
|
2006 Journal Article Prevention of progression of kidney diseaseHarris, David, Thomas, Merlin, Johnson, David W., Nicholls, Kathy and Gillin, Adrian (2006). Prevention of progression of kidney disease. Nephrology, 11 (Supp. 1), S2-S197. doi: 10.1111/j.1440-1797.2006.00505.x |
|
2006 Journal Article Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studiesWojcikowski, Ken, Johnson, David W. and Gobe, Glenda (2006). Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies. Journal of Laboratory And Clinical Medicine, 147 (4), 160-166. doi: 10.1016/j.lab.2005.11.011 |
|
2006 Journal Article LipidsJohnson, David (2006). Lipids. Nephrology, 11 (Supp. 1), S15-S24. doi: 10.1111/j.1440-1797.2006.00602.x |
|
2006 Journal Article Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular functionIsbel, Nicole M., Haluska, Brian, Johnson, David W., Beller, Elaine, Hawley, Carmel and Marwick, Thomas H. (2006). Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function. American Heart Journal, 151 (3), 745-753. doi: 10.1016/j.ahj.2005.06.017 |
